JRS PHARMA is pleased to announce that the JRS Pharma site in Weißenborn, Germany was awarded an EXCiPACT Certificate from DQS for the production of Microcrystalline Cellulose and Silicified Microcrystalline Cellulose as well as Good Distribution Practice for the central logistic warehouse.
This document demonstrates that Microcellulose Weißenborn manufactures and distributes according to the EXCiPACT Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) Certification Standard. The certificate helps drug manufacturers to reduce efforts and costs as they need to either audit new suppliers themselves or commission 3rd party physical audits to demonstrate GMP and / or GDP compliance.
JRS PHARMA's line of Microcrystalline Cellulose products manufactured at the Weißenborn facility include a graduated product portfolio with different grades of VIVAPUR®, EMCOCEL® and HEWETEN® designed for specific formulation needs. MCC is an odorless, tasteless, white powder with a high degree of brightness, derived from highly purified wood pulp. With a wide range of chemical, technical, and economic benefits, MCC is one of the most widely used binder excipients for solid dosage forms.
The EXCiPACT certification covers PROSOLV® SMCC, a High Functionality Excipient based on Microcrystalline Cellulose, produced at JRS PHARMA’s Weißenborn site. JRS PHARMA’s portfolio includes many different grades of PROSOLV® SMCC to provide solutions to various formulation challenges.
For more information on PROSOLV® SMCC, VIVAPUR®, EMCOCEL®, HEWETEN®, or any of JRS PHARMA’s innovative excipient portfolio, please visit jrspharma.com or reach out to your local JRS PHARMA sales representative.
About JRS PHARMA:
JRS PHARMA is a leading manufacturer of excipients, offering a complete portfolio of excipient solutions for the pharmaceutical and nutraceutical industries. Our excipients portfolio includes: high functionality excipients, binders, disintegrants, lubricants, functional fillers, thickeners, stabilizers, carriers, and coatings. In addition to our wide range of excipients, we offer excellent technical and formulation support to address the needs of our customers. In 2018, the JRS Microcrystalline Cellulose Production Network expanded into Asia and opened a new state-of-the-art production site in Changzhou, China. An additional site in India will follow in 2019.